Skip to content
A

Atakan Turgutkaya

Publications (4)

Nocardiosis Associated with Novel Agents at Relapsed Multiple Myeloma: Case Series

Atakan Turgutkaya, Zahit Bolaman, Emel Ceylan, Murat Telli, Berna Gültekin Korkmazgil, Can Karaman & Irfan Yavasoglu · International Blood Research & Reviews · 2019

Nocardiosis is a gram positive bacterial infection caused by aerobicactinomycetes. It’s nonspesific presentation and radiographic findings usually make it undiagnosed with highly fatal outcomes. The patients with intracelluler defects are prone to nocardiosis. Multiplemyelom(MM)...

Open access Research Article 10.9734/ibrr/2019/v10i130111

Is Defibrotide Prophylaxis Effective on Graft Versus Host Disease in Patients with Allogeneic Stem Cell Transplantation?

Irfan Yavasoglu, Atakan Turgutkaya, Hilal Eroğlu Küçükdiler, Gürhan Kadıköylü, Gökhan Sargın & Ali Zahit Bolaman · International Blood Research & Reviews · 2022

Introduction: Sinusoidal obstruction syndrome (SOS) is one of the complications of allogeneic stem cell transplantation (allo-SCT). Defibrotide (DF) is used effectively in SOS prophylaxis and treatment. Graft versus host disease (GVHD) is a significant cause of morbidity and mort...

Open access Research Article 10.9734/ibrr/2022/v13i430184

Investigation of FMS-Like Tyrosine Kinase 3 Mutation Frequency in Myelodysplastic Syndrome

Nesim Akin, Atakan Turgutkaya, Sare İlknur Yavaşoğlu, Esra Örenlili Yaylagül, Celal Ülger, Ali Zahit Bolaman & Irfan Yavasoglu · International Blood Research & Reviews · 2021

Introduction: FMS-Like Tyrosine Kinase Class 3 (FLT3) mutations harbor poor prognosis, high relapse, and decreased overall survival in acute myeloblastic leukemia (AML). This mutation is also known to be demonstrated in myelodysplastic syndrome (MDS), chronic myelomonocytic leuke...

Open access Research Article 10.9734/ibrr/2021/v13i130163

Hypocholesterolemia and Statins in Multiple Myeloma

Irfan Yavasoglu & Atakan Turgutkaya · International Blood Research & Reviews · 2021

Statins are lipid-lowering agents. They also have immunomodulatory, anti-inflammatory, anti-angiogenic, and anti-proliferative functions. In this context, they are demonstrated to have beneficial effects on mortality in several malignancies including esophageal, breast, lung, liv...

Open access Research Article 10.9734/ibrr/2021/v12i430156